More on Tempur-Pedic (TPX): Q3 beats estimates on a 30% jump in Y/Y sales globally. Operating...


More on Tempur-Pedic (TPX): Q3 beats estimates on a 30% jump in Y/Y sales globally. Operating margins rose 8.8% due to improved overall leverage, despite being partially offset by an increase in marketing expenses and higher commodity costs. The company raises FY11 guidance, now seeing its EPS to be around $3.12 - $3.17 per share on revenue of between $1.4B - $1.45B. Despite the better numbers, shares are -4.8% AH.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs